Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
dc.contributor.author | Tan, D. | |
dc.contributor.author | Fernandez, S. | |
dc.contributor.author | French, M. | |
dc.contributor.author | Price, Patricia | |
dc.date.accessioned | 2017-01-30T12:19:00Z | |
dc.date.available | 2017-01-30T12:19:00Z | |
dc.date.created | 2016-09-12T08:36:57Z | |
dc.date.issued | 2009 | |
dc.identifier.citation | Tan, D. and Fernandez, S. and French, M. and Price, P. 2009. Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?. Clinical Immunology. 132 (1): pp. 63-70. | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/20399 | |
dc.identifier.doi | 10.1016/j.clim.2009.03.518 | |
dc.description.abstract |
We evaluated NK cell subsets and functions in previously immunodeficient HIV patients responding to ART. Cytokine receptor mRNA was quantitated in purified CD56+ cells. Data were correlated with CD4+ T-cell counts and IFN? responses to CMV. NK cell IFN? responses to K562 cells and proportions of CD56lo NK cells were correlated in patients (p < 0.001) and both were lower than in controls (p < 0.001 and p = 0.008, respectively), so all patients had poor NK cell function. Proportions of CD56hi NK cells correlated inversely with current CD4+ T-cell counts (p = 0.006) and perforin expression in CD56hi NK cells was higher in patients than controls (p < 0.05). Hence increased proportions and cytolytic function of CD56hi NK cells may partially compensate for CD4+ T-cell deficiency. NK cell IFN? responses correlated inversely with expression of IL-10 and IL-12 receptor mRNA. Expression of these transcripts is reduced by exposure to the cytokines, which may reflect immune activation in immunodeficient patients. © 2009 Elsevier Inc. All rights reserved. | |
dc.publisher | Academic Press | |
dc.title | Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy? | |
dc.type | Journal Article | |
dcterms.source.volume | 132 | |
dcterms.source.number | 1 | |
dcterms.source.startPage | 63 | |
dcterms.source.endPage | 70 | |
dcterms.source.issn | 1521-6616 | |
dcterms.source.title | Clinical Immunology | |
curtin.department | School of Biomedical Sciences | |
curtin.accessStatus | Fulltext not available |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |